Mineralys Therapeutics Inc (MLYS)

$9.56 +0.03 (0.31%)
Market Cap 476.43M
Revenue (ttm) 0.00
Net Income (ttm) -177.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 335,400
Avg Vol 254,772
Day's Range N/A - N/A
Shares Out 49.84M
Stochastic %K 27%
Beta 1.44
Analysts Strong Sell
Price Target $32.00

Latest News on MLYS

Mineralys Therapeutics, Inc. (MLYS) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 1:38 PM EST - 10 days ago

Mineralys Therapeutics, Inc. (MLYS) Q4 2024 Earnings Call Transcript

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Feb 12, 2025, 7:00 AM EST - 10 days ago

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025

Feb 5, 2025, 4:05 PM EST - 17 days ago

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025

Mineralys Therapeutics: Lorundrostat Is Worth A Shot In 2025 For Hypertension

Jan 19, 2025, 8:18 PM EST - 4 weeks ago

Mineralys Therapeutics: Lorundrostat Is Worth A Shot In 2025 For Hypertension

Mineralys Therapeutics, Inc. (MLYS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 10:00 PM EST - 3 months ago

Mineralys Therapeutics, Inc. (MLYS) Q3 2024 Earnings Call Transcript

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 11, 2024, 4:05 PM EST - 3 months ago

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mineralys Therapeutics to Participate in Upcoming Investor Conferences

Nov 5, 2024, 4:05 PM EST - 3 months ago

Mineralys Therapeutics to Participate in Upcoming Investor Conferences

Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024

Nov 4, 2024, 4:05 PM EST - 3 months ago

Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024

The Schall Law Firm Invites Investors To Join An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

Oct 24, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

Oct 22, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

The Schall Law Firm Encourages Investors To Join An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

Oct 20, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Investors To Join An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

Oct 18, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Securities Fraud

Oct 16, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Securities Fraud

The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Mineralys Therapeutics Inc For Possible Securities Fraud

Oct 14, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Investors To Take Part In An Inquiry Into Mineralys Therapeutics Inc For Possible Securities Fraud

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Possible Securities Fraud

Oct 10, 2024, 11:00 AM EDT - 4 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Possible Securities Fraud

The Schall Law Firm Invites Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Possible Securities Fraud

Oct 2, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Invites Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Possible Securities Fraud

Mineralys Therapeutics, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Sep 29, 2024, 11:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. Is Being Investigated For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Securities Related Infractions

Sep 28, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Invites Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Securities Related Infractions

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And Shareholders Are Urged To Help The Schall Law Firm

Sep 25, 2024, 11:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And Shareholders Are Urged To Help The Schall Law Firm

Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension

Sep 25, 2024, 8:00 AM EDT - 5 months ago

Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension

The Schall Law Firm Invites Investors To Join An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws

Sep 24, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Shareholders to Learn More About the Investigation

Sep 24, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Shareholders to Learn More About the Investigation

Mineralys Therapeutics, Inc. May Have Defrauded The Public And Shareholders Are Urged To Help The Schall Law Firm Investigate

Sep 23, 2024, 11:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. May Have Defrauded The Public And Shareholders Are Urged To Help The Schall Law Firm Investigate

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Sep 23, 2024, 10:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

The Schall Law Firm Seeks Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws

Sep 22, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Seeks Investor Participation In An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Shareholders to Inquire about Securities Investigation

Sep 22, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Shareholders to Inquire about Securities Investigation

Mineralys Therapeutics, Inc. Is Being Investigated By The Schall Law Firm For Securities Fraud And Stakeholders Are Urged To Contribute

Sep 21, 2024, 11:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. Is Being Investigated By The Schall Law Firm For Securities Fraud And Stakeholders Are Urged To Contribute

The Schall Law Firm Has Launched An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws And Affected Investors Should Reach Out

Sep 20, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Has Launched An Inquiry Into Mineralys Therapeutics Inc For Violating Securities Laws And Affected Investors Should Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Shareholders to Connect

Sep 20, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Shareholders to Connect

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Take Part

Sep 19, 2024, 11:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Take Part

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Stockholders to Inquire about Securities Investigation

Sep 19, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Investors to Learn More About the Investigation

Sep 18, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Investors to Learn More About the Investigation

Mineralys In Hypertension: Upcoming Catalysts And Strong Positioning

Sep 17, 2024, 1:27 PM EDT - 5 months ago

Mineralys In Hypertension: Upcoming Catalysts And Strong Positioning

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Stockholders Should Reach Out

Sep 17, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Stockholders Should Reach Out

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Sep 17, 2024, 10:00 AM EDT - 5 months ago

Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Investors to Connect

Sep 16, 2024, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Investors to Connect

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Shareholders Should Reach Out

Sep 15, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Shareholders Should Reach Out

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Stockholders Should Reach Out

Sep 13, 2024, 11:00 AM EDT - 5 months ago

The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Stockholders Should Reach Out